Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice

Pharmacology Biochemistry and Behavior

Volumn 55, Issue 2, 1996, Pages 281-287

  De Sarro, Giovambattista ^a,d   Ongini, Ennio ^b   Bertorelli, Rosalia ^b   Aguglia, Umberto ^a   De Sarro, Angela ^c  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b Schering Plough Research Institute   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d Policlinico Mater Domini   (Italy)

Author keywords

5,7DCKA (5,7 dichlorokynurenic acid); Audiogenic seizures; Dihydropyridine sensitive Ca2+ channels; Felbamate; NBQX (2,3 dihydroxy 6 nitro 7 sulphamoylbenzo(F)quinoxoline); Voltage dependent K+ channels

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 5,7 DICHLOROKYNURENIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ALPHA DENDROTOXIN; ANTICONVULSIVE AGENT; CALCIUM CHANNEL; FELBAMATE; GLUTAMATE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDIOGENIC SEIZURE; CONTROLLED STUDY; FEMALE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL;

ACOUSTIC STIMULATION; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; CONVULSANTS; ELECTROSHOCK; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; INJECTIONS, INTRAVENTRICULAR; ION CHANNEL GATING; KYNURENIC ACID; MALE; MICE; MICE, INBRED DBA; MOTOR ACTIVITY; POTASSIUM CHANNELS; PROPYLENE GLYCOLS; QUINOXALINES;

ANIMALIA;

EID: 0030272388     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00085-8     Document Type: Article

References (36)

1. 1. Bisaga, A.; Krzascik, P.; Jankowska, E.; Palejko, W.; Kostowski, W.; Danysz, W. Effect of glutamate receptor antagonists on N-methyl-D-aspartate and (S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced convulsant effects in mice and rats. Eur. J. Pharmacol. 242:213-219; 1993.
2. 2. Chapman, A. G.; Croucher, M. J.; Meldrum, B. S. Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures. Arzeimittleforschung/Drug Res. 34:1261-1264; 1984.
3. 3. Chapman, A. G.; De Sarro, G. B.; Premachandra, N.; Meldrum, B. S. Bidirectional effects of β-carbolines in reflex epilepsy. Brain Res. Bull. 19:337-346; 1987.
4. 4. Chapman, A. G.; Smith, S. E.; Meldrum, B. S. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466 in mice. Epilepsy Res. 9:92-96; 1991.
5. 5. Chronopoulos, A.; Stafstrom, C.; Thurber, S.; Hyde, P.; Mikati, M.; Holmes, G. L. Neuroprotective effect of felbamate after kainic acid-induced status epilepticus. Epilepsia 34:359-366; 1993.
6. 6. Coffin, V. L.; Cohen-Williams, M.; Barnett, A. Selective antagonism of the anticonvulsant effects of felbamate by glycine. Eur. J. Pharmacol. 256:R9-R10; 1994.
7. 7. De Sarro, G. B.; Croucher, M. J.; Meldrum, B. S. Anticonvulsant actions of DS 103-282: Pharmacological studies in rodents and the baboon, Papio papio. Neuropharmacology 23:526-530; 1984.
8. 8. De Sarro, G. B.; Meldrum, B. S.; Nisticò, G. Anticonvulsant effects of some calcium entry blockers in DBA/2 mice. Br. J. Pharmacol. 93:247-256; 1988.
9. 9. De Sarro, G. B.; Ascioti, C.; Donato Di Paola, E.; Vidal, M. J.; De Sarro, A. Effects of antiepileptic drugs, calcium channel blockers and other compounds on seizures induced by activation of voltage-dependent L calcium channel in DBA/2 mice. Gen. Pharmacol. 23:1205-1216; 1992.
10. 10. De Sarro, G. B.; Ongini, E.; Bertorelli, R.; Aguglia, U.; De Sarro, A. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice. Eur. J. Pharmacol. 262:11-19; 1994.
11. 11. De Sarro, G. B.; Renne, S.; Nava, F.; De Sarro, A. Fenbufen pretreatment potentiates the anticonvulsant activity of CPPene and NBQX in DBA/2 mice. J. Pharm. Pharmacol. 46:1017-1022; 1994.
12. 12. De Sarro, G. B.; Ammendola, D.; Nava, F.; De Sarro, A. Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice. Brain. Res. 671:131-140; 1995.
13. 13. Domenici, M. R.; Sagratella, S.; Ongini, E.; Longo, R.; Scotti de Carolis, A. The new anticonvulsant drug felbamate displays in vitro antiepileptic effects as a broad spectrum excitatory amino acid antagonist. Eur. J. Pharmacol. 271:259-263; 1994.
14. 14. Engstrom, F. L.; Woodbury, D. M. Seizure susceptibility in DBA and C57 mice: The effects of various convulsants. Epilepsia 29:389-395; 1988.
15. 15. Foster, A. C.; Kemp, J. A.; Leeson, P. D.; Grimwood, S.; Donald, A. E.; Marshall, G. R.; Priestley, T.; Smith, J. D.; Carling, R. W. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain. Mol. Pharmacol. 41:914-922; 1992.
16. 16. Gordon, R.; Gels, M.; Diamantis, W.; Sofia, R. D. Interaction of felbamate and diazepam against maximal electroshock seizures and chemoconvulsants in mice. Pharmacol. Biochem. Behav. 40:109-113; 1991.
17. 17. Kaku, D. A.; Goldberg, M. P.; Choi, D. W. Antagonism of non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose. Brain Res. 554:344-347; 1991.
18. 18. Litchfield, J. T.; Wilcoxon, F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:99-111; 1949.
19. 19. Macdonald, R. L.; Kelly, K. M. Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia 35:S41-S50; 1994.
20. 20. McCabe, R. T.; Wasterlain, C. G.; Kucharczyk, N.; Sofia, R. D.; Vogel, J. R. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors. J. Pharmacol. Exp. Ther. 264:1248-1252; 1993.
21. 21. Palmer, K. J.; McTavish, D. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy. Drugs 45:1041-1065; 1993.
22. A receptors. Ann. Neurol. 35:229-234; 1994.
23. 23. Rogawski, M. A. Therapeutic potential of excitatory amino acid antagonists: Channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14:325-332; 1993.
24. ++ channels. Nature 303:535-537; 1983.
25. 25. Seyfried, T. N.; Glaser, G. H. A review of mouse mutants of genetic models of epilepsy. Epilepsy 26:143-150; 1985.
26. 26. Sheardown, M. J.; Nielsen, E. O.; Hansen, A. J.; Jacobsen, P.; Honorè, T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science 247:571-574; 1990.
27. 27. Smith, S. E.; Durmeller, N.; Meldrum, B. S. The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animals models of reflex epilepsy. Eur. J. Pharmacol. 201:179-183; 1991.
28. 28. Subramaniam, S.; Rho, J. M.; Penix, L.; Donevan, S. D.; Fielding R. P.; Rogawski, M. A. Felbamate block of the N-methyl-D-aspartate receptor. J. Pharmacol. Exp. Ther. 273:878-886; 1995.
29. 29. Swinyard, E. A.; Woodhead J. H.; Franklin, M. R.; Sofia, R. D.; Kupferberg, H. J. The effect of chronic felbamate administration on anticonvulsant activity and hepatic drug-metabolizing enzymes in mice and rats. Epilepsia 28:295-300; 1987.
30. 30. Taylor, L. A.; McQuade, R.; Tice, M. A. B. Felbamate, a novel antiepileptic drug, reverses N-methyl-D-aspartate/glycine-stimulated increases in intracellular calcium concentration. Eur. J. Pharmacol. 289:229-233; 1995.
31. 31. Turski, L.; Klockgether, T.; Turski, W. A.; Ikonomidou, C.; Schwarz, M.; Sontag, K. H. Muscle relaxant action of excitatory amino acid antagonists. Sites of action. In: Cavalheiro, E. A.; Lehmann, J.; Turski, L., eds. Frontiers in excitatory amino acid research. New York: Alan R. Liss; 1988:343-350.
32. 32. Turski, L.; Jacobsen, P.; Honorè, T.; Stephens, D. N. Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f) quinoxaline. J. Pharmacol. Exp. Ther. 260:742-747; 1992.
33. 33. Upton, N. Mechanisms of action of new antiepileptic drugs: Rational design and serendipitous findings. Trends Pharmacol. Sci. 15:456-463; 1994.
34. 3H] DCKA-labeled strychnine-insensitive glycine receptors in human postmortem brain. Exp. Neurol. 129:244-250; 1994.
35. 35. White, H. S.; Harmsworth, W. L.; Sofia, R. D.; Wolf, H. H. Felbamate modulates the strychnine-insensitive glycine receptor. Epilepsy Res. 20:41-48; 1995.
36. 36. Yamaguchi, S.; Rogawski, M. Effects of anticonvulsant drugs on 4-aminopyridine induced seizures in mice. Epilepsy Res. 11:9-16; 1992.